IRMD - IRadimed Corporation
| Previous Close | 25.76 |
| Open | 25.70 |
| Bid | 19.10 x 2900 |
| Ask | 32.00 x 1400 |
| Day's Range | 24.71 - 25.75 |
| 52 Week Range | 16.68 - 29.80 |
| Volume | 44,635 |
| Avg. Volume | 68,330 |
| Market Cap | 295M |
| Beta (5Y Monthly) | 1.56 |
| PE Ratio (TTM) | 38.89 |
| EPS (TTM) | 0.66 |
| Earnings Date | Oct 30, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 31.00 |
- GlobeNewswire
IRADIMED CORPORATION Completes CE Mark Renewal Process For Its MRI Compatible Patient Vital Signs Monitoring System
IRADIMED CORPORATION (IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital signs monitoring system that are designed for use during MRI procedures, today announced that it resumed shipments of its MRI compatible patient vital signs monitoring systems into European Commission markets after completing the CE Mark renewal process.
- Simply Wall St.
Do You Like IRadimed Corporation (NASDAQ:IRMD) At This P/E Ratio?
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). To keep it...
- Thomson Reuters StreetEvents
Edited Transcript of IRMD earnings conference call or presentation 30-Oct-19 3:00pm GMT
Q3 2019 IRadimed Corp Earnings Call
- Simply Wall St.
Independent Director Monty Allen Just Sold A Bunch Of Shares In IRadimed Corporation (NASDAQ:IRMD)
Anyone interested in IRadimed Corporation (NASDAQ:IRMD) should probably be aware that the Independent Director, Monty...
- Zacks
IRadimed (IRMD) Q3 Earnings and Revenues Beat Estimates
iRadimed (IRMD) delivered earnings and revenue surprises of 53.33% and 1.15%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
IRADIMED CORPORATION Announces Third Quarter 2019 Financial Results
Reports third quarter 2019 revenue of $10.0 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Updates full-year financial guidance WINTER SPRINGS, Fla., Oct..
- Zacks
IRadimed (IRMD) Reports Next Week: Wall Street Expects Earnings Growth
IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Why IRadimed Corporation (NASDAQ:IRMD) Could Be Worth Watching
IRadimed Corporation (NASDAQ:IRMD), which is in the medical equipment business, and is based in United States...
- GlobeNewswire
IRADIMED CORPORATION to Hold 2019 Third Quarter Financial Results Conference Call on October 30th
WINTER SPRINGS, Fla., Oct. 16, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 third quarter financial results before the.
- GlobeNewswire
IRADIMED CORPORATION Resolves Warning Letter Related to Its Infusion Pump System
IRADIMED CORPORATION (IRMD), today announced that it received a close-out letter from the U.S. Food and Drug Administration resolving all issues cited in the August 2014 warning letter. “The resolution of the warning letter is the result of countless hours of work performed by everyone at IRADIMED. The Company does not expect a significant impact to its business or financial performance resulting from the close-out letter.
- Simply Wall St.
Did IRadimed Corporation (NASDAQ:IRMD) Insiders Sell Shares?
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
- GuruFocus.com
4 Levels of Information
What information to look for when researching a company Continue reading...
- Simply Wall St.
Shareholders Are Thrilled That The IRadimed (NASDAQ:IRMD) Share Price Increased 141%
IRadimed Corporation (NASDAQ:IRMD) shareholders have seen the share price descend 13% over the month. But that doesn't...
- Market Exclusive
Market Morning: Fed Debates, Johnson Loses, Hong Kong Wins, Italy Gets New Government
To Cut Or Not to Cut? Lagarde Answers the Question Federal Reserve officials are prevaricating over whether to cut dollar interest rates at the next Federal Open Market Committee meeting on September 17-18. St. Louis Fed President James Bullard is the most dovish (from the inflation side) and hawkish (from the saver side) calling for […]The post Market Morning: Fed Debates, Johnson Loses, Hong Kong Wins, Italy Gets New Government appeared first on Market Exclusive.
- GlobeNewswire
IRADIMED CORPORATION to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
WINTER SPRINGS, Fla., Aug. 27, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie McDonnell, President and Chief Executive Officer, Roger Susi, Chairman.
- Simply Wall St.
IRadimed Corporation (NASDAQ:IRMD): What Does Its Beta Value Mean For Your Portfolio?
If you own shares in IRadimed Corporation (NASDAQ:IRMD) then it's worth thinking about how it contributes to the...
- GuruFocus.com
Market Volatility: A Time for Testing
In these days of wild market fluctuations, revisiting your portfolio through the dual lenses of circles of competence and comfort can be quite helpful Continue reading...
- Thomson Reuters StreetEvents
Edited Transcript of IRMD earnings conference call or presentation 30-Jul-19 3:00pm GMT
Q2 2019 IRadimed Corp Earnings Call
Motley FoolIradimed (IRMD) Q2 2019 Earnings Call Transcript
IRMD earnings call for the period ending June 30, 2019.
- Zacks
IRadimed (IRMD) Beats Q2 Earnings and Revenue Estimates
iRadimed (IRMD) delivered earnings and revenue surprises of 33.33% and 3.55%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
IRADIMED CORPORATION Announces Second Quarter 2019 Financial Results
Reports second quarter 2019 revenue of $9.2 millionReports second quarter 2019 GAAP diluted EPS of $0.17 and non-GAAP diluted EPS of $0.20Updates full year earnings guidance.
- GlobeNewswire
IRADIMED CORPORATION Names Leslie McDonnell as President and Chief Executive Officer
IRADIMED CORPORATION (IRMD) announced today that its Board of Directors unanimously appointed Leslie McDonnell, to succeed Roger Susi as President and Chief Executive Officer. Mr. Susi will step down as President and CEO on August 19, 2019 after leading the Company since its founding 27 ago. Mr. Susi will remain highly engaged with the company by continuing as its Chairman and in the new position of Chief Technology Officer.
- Simply Wall St.
What Can We Make Of IRadimed Corporation’s (NASDAQ:IRMD) High Return On Capital?
Today we'll look at IRadimed Corporation (NASDAQ:IRMD) and reflect on its potential as an investment. Specifically...
- GuruFocus.com
Reducing Blind Spots
How to not miss important items when researching a business Continue reading...
